Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M83.8Revenue (TTM) $M0.2Net Margin (%)-48,979.1Altman Z-Score-6.9
Enterprise Value $M49.8EPS (TTM) $-1.4Operating Margin %-49,521.5Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.7Pre-tax Margin (%)-48,977.9Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %-18.3Quick Ratio3.3Cash flow > EarningsY
Price/Sales3765-y EBITDA Growth Rate %0.3Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-89.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M60.8ROIC % (ttm)-530.1Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARWRGeorge Soros 2014-06-30 Sold Out -0.01%$9.79 - $18.28
($13.09)
$ 1.38-89%Sold Out0
ARWRGeorge Soros 2014-03-31 Buy 0.01%$9.92 - $26.57
($17.36)
$ 1.38-92%New holding44,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARWR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GIVEN DOUGLAS BDirector 2016-10-14Sell12,000$6.72-79.46view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-82.75view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-82.75view
Myszkowski Kenneth AllenCFO 2015-12-30Sell23,347$6.13-77.49view
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-82.77view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-78.16view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-78.16view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-90.61view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-90.81view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-90.94view

Quarterly/Annual Reports about ARWR:

News about ARWR:

Articles On GuruFocus.com
Arrowhead Research Making Headway In The RNAi Therapy Platform Mar 09 2015 
Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Dec 05 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Dec 05 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead... Dec 02 2016
INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers... Dec 02 2016
ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Dec 01 2016
Arrowhead Halts 3 Drug Projects, Axes Jobs (ARWR) Dec 01 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Nov 30 2016
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of... Nov 30 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead... Nov 30 2016
Arrowhead, Coca-Cola Lead Wednesday’s 52-Week Low Club Nov 30 2016
Arrowhead Shows Biotech Risks Come in Flavors Nov 30 2016
Arrowhead Pharmaceuticals Inc (ARWR): Any Good Hearted Billionaires Out There (Willing To Pick Up... Nov 30 2016
Arrowhead Pharma Shares Destroyed by Development Announcement Nov 30 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Arrowhead Pharmaceuticals, Inc. of... Nov 30 2016
Top Analyst Upgrades and Downgrades: Arrowhead Pharma, Cognizant, Goldman Sachs, HP, Splunk,... Nov 30 2016
Arrowhead Pharma Downgraded Following EX-1 RNAi Program Discontinuations Nov 30 2016
Arrowhead downgraded by Chardan Capital Markets, Piper Jaffray, Cantor Fitzgerald and William Blair Nov 30 2016
Arrowhead Pharma shares plummet 60% on discontinued drug development Nov 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)